Retina Group of Florida

Fort Lauderdale, Florida 33334

2 studies enrolling now · 39 studies all time

What they study most

Age Related Macular Degeneration, Age-Related Macular Degeneration, Age-related Macular Degeneration, Age-related Macular Degeneration (AMD), Cataract, Central Retinal Vein Occlusion, Central Serous Retinopathy, Diabetic Macular Edema, Diabetic Retinopathy, Epiretinal Membrane, Geographic Atrophy, Geographic Atrophy (GA)

Studies at this site

• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — Recruiting now
• A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Recruiting now
• A 2-year Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD) (LUCIA) Primary Efficacy Will be Determined at Week 56 — Running, not enrolling
• A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME — Running, not enrolling
• 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration — Running, not enrolling
• Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy — Completed
• A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR) — Completed
• A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) — Completed
• A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK — Running, not enrolling
• Vamikibart in Participants With Uveitic Macular Edema — Completed
• A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) — Completed
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema — Completed
• A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) — Running, not enrolling
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration — Completed
• A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
• Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE) — Completed
• A Study of NGM621 in Participants With Geographic Atrophy — Completed
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR) — Stopped early
• Anti-VEGF Treatment for Prevention of PDR/DME — Completed
• Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) — Completed
• Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis — Completed
• Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) — Completed
• MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301 — Completed
• Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis — Completed
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema — Completed
• A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) — Stopped early
• Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial — Completed
• Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO — Completed
• Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study — Completed
• Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema — Completed
• Age-Related Eye Disease Study 2 (AREDS2) — Completed
• Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment — Stopped early
• A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration — Status unconfirmed
• Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) — Completed